AddLife Expands Medtech Business in Portugal Through Acquisition of Surgical Device Distributor MoonSurge
AddLife has announced the acquisition of MoonSurge, Importação e Exportação de Material Médico, LDA, a leading Portuguese distributor of high-quality medical devices and advanced surgical technologies. The acquisition represents another step in AddLife’s strategy to strengthen its presence in specialized medical technology markets and expand its portfolio of products and services supporting modern surgical procedures.
Following the completion of the transaction, MoonSurge will operate as an independent subsidiary of MBA SURGICAL EMPOWERMENT, which is part of AddLife’s Business Area Medtech. The arrangement will allow MoonSurge to continue operating with its established market expertise and customer relationships while benefiting from its connection to the broader AddLife group.
Based in Portugal, MoonSurge specializes in distributing advanced medical devices used in several surgical specialties, including general surgery, urology, gynaecology and cardiac surgery. The company has a particular focus on minimally invasive surgical procedures, an area of healthcare that continues to develop as hospitals and healthcare professionals increasingly adopt advanced technologies to support surgical treatment.
MoonSurge generates annual revenue of approximately EUR 5 million and employs 14 people. Through its established distribution network and partnerships with specialized European manufacturers, the company supplies medical technologies to healthcare professionals and hospital institutions throughout the Portuguese market.
The acquisition strengthens AddLife’s position in advanced surgical technology and expands the range of solutions available through its Medtech business. It also supports the group’s ambition to provide specialized medical products that create value for healthcare professionals and patients.
MoonSurge Strengthens AddLife’s Advanced Surgical Technology Portfolio
MoonSurge has established its position in Portugal by focusing on the distribution of high-quality medical devices designed for specialized surgical applications. Its product portfolio covers several important clinical areas, including general surgery, urology, gynaecology and cardiac surgery.
These specialties require a wide range of medical technologies and surgical instruments to support different procedures and clinical requirements. MoonSurge works with international partners to bring specialized products to healthcare professionals and hospital institutions.
One of the company’s primary areas of focus is minimally invasive surgery. These procedures use specialized instruments and technologies to perform operations through smaller incisions or other less invasive approaches compared with traditional open surgery.
Minimally invasive techniques are used across multiple surgical specialties and can offer clinical advantages in appropriately selected patients. Depending on the procedure and individual circumstances, these approaches may help reduce surgical trauma, support recovery and shorten hospital stays.
The availability of advanced surgical devices is therefore important for hospitals seeking to develop their surgical capabilities and provide healthcare professionals with access to modern clinical technologies.
MoonSurge’s distribution activities are supported by partnerships with European manufacturers recognized for technological innovation in specialized medical markets.
These partnerships enable the company to offer differentiated medical technologies that address specific clinical needs. By concentrating on niche product segments, MoonSurge provides healthcare institutions with access to specialized equipment and solutions that may not be widely available through broader medical device distribution channels.
Its established relationships with manufacturers, hospitals and healthcare professionals have helped the company develop a presence in Portugal’s medical technology market.
Through the acquisition, AddLife gains access to these existing relationships and a specialized distribution platform focused on advanced surgical products.
MoonSurge to Operate as an Independent Subsidiary of MBA SURGICAL EMPOWERMENT
Under the new ownership structure, MoonSurge will become an independent subsidiary of MBA SURGICAL EMPOWERMENT, which operates within AddLife’s Medtech business area.This structure is intended to support continuity in MoonSurge’s operations while providing opportunities for collaboration with MBA and the wider AddLife organization.
MBA SURGICAL EMPOWERMENT focuses on providing specialized surgical solutions and supporting healthcare professionals through advanced medical technologies. The addition of MoonSurge complements this business by expanding its geographical reach and strengthening its presence in the Portuguese market.
The relationship also creates opportunities to share expertise across the Iberian region, particularly between businesses operating in Portugal and other parts of the market.For MoonSurge, becoming part of MBA provides access to a larger organizational network while allowing the company to maintain its independent operating structure.
This approach is consistent with AddLife’s broader business model, which involves acquiring specialized companies and supporting their continued development within the group.Rather than eliminating the individual identity and market expertise of acquired businesses, AddLife’s model allows companies to continue building on their existing strengths while benefiting from group-level resources and relationships.
For customers, maintaining operational continuity can be important because specialized medical device distributors often depend on established relationships with surgeons, hospitals, purchasing departments and manufacturers.MoonSurge’s independent subsidiary structure is expected to support the continuation of these relationships while creating opportunities for further business development.
Acquisition Aligns With AddLife’s Long-Term Growth Strategy
The acquisition of MoonSurge is consistent with AddLife’s previously communicated acquisition criteria and its strategy of expanding in attractive medical technology segments with long-term growth potential.AddLife focuses on acquiring and developing companies that operate in specialized healthcare and life science markets. These businesses often provide products and services that require technical knowledge, industry experience and close relationships with customers.
Advanced surgical technology represents an important area within the medical technology sector because healthcare providers continue to seek innovative solutions that support clinical development and surgical performance.The growing importance of specialized medical devices also creates opportunities for distributors with strong manufacturer relationships and established access to healthcare institutions.
By acquiring MoonSurge, AddLife is expanding its presence in a specialized product segment while strengthening its geographical position in Portugal.The transaction also complements the group’s existing Medtech operations through the addition of a business focused on advanced surgical technologies.
MoonSurge’s established portfolio and partnerships with European manufacturers provide AddLife with an additional platform for serving hospitals and medical professionals.The acquisition may also create opportunities for knowledge-sharing and collaboration between MoonSurge and MBA SURGICAL EMPOWERMENT.
Combining specialist expertise across the businesses could support the development of their product offerings, strengthen customer relationships and improve access to innovative medical technologies across the Iberian market.The transaction therefore reflects AddLife’s approach of pursuing targeted acquisitions that complement its existing operations rather than focusing exclusively on increasing overall business size.
MBA Leadership Welcomes MoonSurge to the Group
Carlos Pinto, CEO of MBA SURGICAL EMPOWERMENT, welcomed the acquisition and highlighted the similarities between the organizations’ business cultures.
“We are delighted to welcome MoonSurge to MBA. We share a culture built on close customer relationships, specialist expertise and an entrepreneurial spirit, and we believe this partnership strengthens our ability to continue growing and developing our business in Portugal,” said Pinto.
His comments emphasize the importance of shared business values and customer relationships in bringing the two organizations together.Both businesses operate in specialized medical technology markets where product knowledge, technical expertise and close cooperation with healthcare professionals are important factors.
For MBA, MoonSurge’s established presence in Portugal provides an opportunity to strengthen its operations in the market and build on the expertise already available within the organization.The acquisition also creates an opportunity to expand collaboration across the Iberian region.
By combining MoonSurge’s experience in Portugal with MBA’s capabilities, the businesses can explore opportunities to develop their market presence and strengthen their relationships with medical professionals and hospital institutions.The focus will remain on providing specialized surgical technologies that address the needs of healthcare providers.
MoonSurge Leadership Highlights a New Chapter After 23 Years
António Leal, CEO of MoonSurge, described the acquisition as an important milestone in the company’s development following more than two decades of operations.
“After 23 years in business, we continue to create new opportunities for growth for our outstanding team. Becoming part of a group such as AddLife marks an important new chapter in our journey. The opportunity to share Iberian expertise with MBA is both an exciting challenge and a great privilege. We look forward to building on our experience and achieving continued success together,” said Leal.
His comments reflect the company’s intention to continue developing its business while creating new opportunities for its employees and customers.Since its establishment, MoonSurge has developed expertise in the distribution of specialized medical devices and established relationships with European manufacturers and Portuguese healthcare institutions.
The acquisition provides a new organizational framework for continuing this work while creating opportunities to benefit from a larger group’s experience and market connections.The company’s 14 employees represent an important part of its specialist operating model. Their experience in medical device distribution and knowledge of the Portuguese healthcare market contribute to MoonSurge’s ability to serve hospitals and healthcare professionals.
Maintaining this expertise will be important as the company enters its next phase of development under AddLife’s ownership.The opportunity to share expertise with MBA may also help the company strengthen its understanding of regional market requirements and explore additional areas of collaboration.
Supporting Innovation in Minimally Invasive Surgery
The acquisition also highlights the importance of advanced medical technologies in the development of modern surgical practices.Minimally invasive surgery has become an important part of treatment across multiple clinical specialties. It involves the use of specialized instruments, imaging technologies and surgical equipment to perform procedures through smaller access points or other less invasive techniques.
These approaches can be used in general surgery, urology, gynaecology and cardiac surgery, among other areas.The continued development of surgical technologies has created demand for specialized products that support precision, procedural efficiency and clinical requirements.
Hospitals and healthcare professionals rely on medical device suppliers to provide access to suitable technologies, technical product knowledge and dependable distribution services.MoonSurge’s partnerships with European manufacturers allow it to supply differentiated products to the Portuguese healthcare market.
By bringing the company into its Medtech business area, AddLife is strengthening its portfolio in an area where technological innovation and specialist expertise play important roles.The acquisition supports the group’s objective of providing solutions that create value for clinicians and patients.It also expands the opportunities available to healthcare institutions seeking access to advanced surgical devices and technologies.
Financial Impact and Transaction Completion
The acquisition of MoonSurge was completed on November 2, 2026.The company generates annual revenue of approximately EUR 5 million and has 14 employees. AddLife expects the transaction to have a marginally positive impact on its earnings per share during the current financial year.
Although the expected earnings contribution is described as marginal, the acquisition represents a strategic addition to AddLife’s Medtech operations.The transaction provides the group with an established medical technology distributor in Portugal, a specialized portfolio covering several surgical disciplines and existing relationships with European manufacturers.
Its contribution is therefore linked not only to current financial performance but also to the potential for future development within AddLife’s medical technology operations.The independent subsidiary structure under MBA SURGICAL EMPOWERMENT is expected to support the company’s continued market activities while providing opportunities to collaborate with other businesses in the group.
AddLife Continues Expanding Its Presence in Specialized Medtech Markets
The acquisition of MoonSurge represents another step in AddLife’s strategy to expand its presence in specialized medical technology markets through targeted acquisitions.With MoonSurge joining MBA SURGICAL EMPOWERMENT, AddLife is strengthening its advanced surgical technology offering and expanding its access to healthcare professionals and hospital institutions in Portugal.
The addition of the Portuguese distributor also creates opportunities for greater collaboration across the Iberian region, particularly through the sharing of specialist expertise and customer relationships.For MoonSurge, the acquisition marks a new chapter after 23 years in business, providing an opportunity to continue developing its operations as part of a larger healthcare-focused group.
For MBA, the transaction strengthens its presence in Portugal and adds a specialized distributor with established relationships in general surgery, urology, gynaecology and cardiac surgery.As healthcare providers continue adopting advanced medical technologies and minimally invasive surgical approaches, specialized distributors will remain important partners in connecting manufacturers with hospitals and clinical professionals.
Through this acquisition, AddLife is reinforcing its commitment to investing in advanced product segments, supporting specialist healthcare businesses and expanding its portfolio of medical technology solutions.The company expects MoonSurge to continue building on its existing market expertise while contributing to the development of AddLife’s broader Medtech business.
Source link: https://www.add.life/
